Market Closed -
Nasdaq
04:00:00 2024-05-09 pm EDT
|
5-day change
|
1st Jan Change
|
11.51
USD
|
+1.23%
|
|
+4.07%
|
0.00%
|
Fiscal Period: December |
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,948
|
-
|
-
|
Enterprise Value (EV)
1 |
4,342
|
4,109
|
3,876
|
P/E ratio
|
7.29
x
|
10.7
x
|
8.71
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.18
x
|
0.17
x
|
0.16
x
|
EV / Revenue
|
0.41
x
|
0.37
x
|
0.32
x
|
EV / EBITDA
|
7.7
x
|
6.7
x
|
5.85
x
|
EV / FCF
|
21.9
x
|
17.6
x
|
-
|
FCF Yield
|
4.56%
|
5.69%
|
-
|
Price to Book
|
1.3
x
|
1.12
x
|
0.97
x
|
Nbr of stocks (in thousands)
|
171,320
|
-
|
-
|
Reference price
2 |
11.37
|
11.37
|
11.37
|
Announcement Date
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
8,826
|
10,615
|
11,201
|
12,139
|
EBITDA
1 |
-
|
537.8
|
563.7
|
613.4
|
662.7
|
EBIT
1 |
-
|
335.5
|
358
|
378.3
|
443.9
|
Operating Margin
|
-
|
3.8%
|
3.37%
|
3.38%
|
3.66%
|
Earnings before Tax (EBT)
1 |
-
|
-177.4
|
146.6
|
194.5
|
248.6
|
Net income
1 |
-53.91
|
-154.6
|
325.5
|
217
|
279.2
|
Net margin
|
-
|
-1.75%
|
3.07%
|
1.94%
|
2.3%
|
EPS
2 |
-7.180
|
-1.310
|
1.559
|
1.064
|
1.306
|
Free Cash Flow
1 |
-
|
137.3
|
197.9
|
233.6
|
-
|
FCF margin
|
-
|
1.56%
|
1.86%
|
2.09%
|
-
|
FCF Conversion (EBITDA)
|
-
|
25.52%
|
35.11%
|
38.09%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
60.79%
|
107.69%
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/28/23
|
2/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
2,375
|
2,577
|
2,616
|
2,656
|
2,759
|
2,786
|
2,834
|
EBITDA
1 |
142.6
|
130.5
|
144.5
|
139.3
|
149.6
|
143
|
157.2
|
EBIT
1 |
91.59
|
81.58
|
94.05
|
84.3
|
90.66
|
87.72
|
89.57
|
Operating Margin
|
3.86%
|
3.17%
|
3.6%
|
3.17%
|
3.29%
|
3.15%
|
3.16%
|
Earnings before Tax (EBT)
|
-14.79
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-6.537
|
-45.75
|
75.57
|
72.82
|
88.37
|
63.42
|
68.27
|
Net margin
|
-0.28%
|
-1.78%
|
2.89%
|
2.74%
|
3.2%
|
2.28%
|
2.41%
|
EPS
2 |
-0.0600
|
-0.2600
|
0.3496
|
0.3368
|
0.4087
|
0.3054
|
0.3282
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/29/24
|
5/2/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
3,385
|
2,394
|
2,161
|
1,928
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
6.294
x
|
4.247
x
|
3.524
x
|
2.909
x
|
Free Cash Flow
1 |
-
|
137
|
198
|
234
|
-
|
ROE (net income / shareholders' equity)
|
-
|
1.77%
|
9.89%
|
9.46%
|
10.5%
|
ROA (Net income/ Total Assets)
|
-
|
0.22%
|
5.72%
|
6.4%
|
6.57%
|
Assets
1 |
-
|
-71,609
|
5,687
|
3,392
|
4,249
|
Book Value Per Share
2 |
-
|
4.960
|
8.720
|
10.10
|
11.70
|
Cash Flow per Share
2 |
-
|
1.790
|
0.4800
|
1.820
|
2.260
|
Capex
1 |
-
|
73.5
|
76.4
|
89.8
|
89.1
|
Capex / Sales
|
-
|
0.83%
|
0.72%
|
0.8%
|
0.73%
|
Announcement Date
|
8/28/23
|
2/29/24
|
-
|
-
|
-
|
Last Close Price
11.37
USD Average target price
16.14
USD Spread / Average Target +41.92% Consensus |
1st Jan change
|
Capi.
|
---|
| 0.00% | 1.95B | | -0.54% | 3.07B | | +14.27% | 1.73B | | +59.77% | 665M | | -19.90% | 487M | | -25.82% | 158M | | -12.04% | 140M | | +1.92% | 69.08M |
Home Healthcare Services
|